Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Elmira, NY MSA — September 2026
Elmira's thin labor pool forces CRA pay to chase the national market.
Chemung County unemployment rose to 4.2% as the civilian labor force fell near 35,700, while local Clinical Research Associate pay climbed to $97,647 — outpacing the $90,956 national median.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Chemung County unemployment: 4.2% — Up from 4.1% in June 2026
- Civilian labor force: ~35,700 — July 2026, signaling contraction
- NY pharma/biotech jobs: 23,643 — Record high, statewide, Aug 2026
- BioSpace postings YoY: -39% — Statewide, signals selective hiring
Key takeaways
Elmira's labor pool is shrinking, not just slow.
Civilian labor force near 35,700 with unemployment drifting to 4.2% reflects a contracting base, not cyclical softness — a structural constraint on any plan to build specialized scientific or regulatory headcount locally.
Clinical Research Associate pay is the standout signal this month.
Metro CRA pay at $97,647 exceeds the national median of $90,956, both rising significantly — a sign that even thin upstate markets must now match or beat national rates to attract clinical talent, eroding any historical geographic discount.
Statewide hiring is selective, not expansive.
New York's record 23,643 pharma/biotech jobs coexist with a 39% year-over-year drop in BioSpace postings, consistent with employers consolidating hiring into fewer, higher-priority roles rather than broad headcount growth.
Lab Technician pay stagnation may mask retention risk, not market calm.
Metro and national Lab Technician pay sit flat to down ($46,904 local, $47,402 national, declining), which could reflect employer caution rather than adequate supply — worth testing against actual offer acceptance and turnover data before assuming the role is low-priority.
Median advertised pay by role — Elmira, NY MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $82,152 | $121,403 | $148,970 | Moderate increase | $131,354 |
| Clinical Research Associate * | $72,812 | $97,647 | $102,276 | Significant increase | $90,956 |
| Lab Technician * | $40,114 | $46,904 | $50,189 | Stable | $47,402 |
| Regulatory Affairs Specialist * | $70,044 | $96,238 | $116,373 | Moderate decline | $104,000 |
| Clinical Data Manager * | $103,367 | $123,978 | $136,385 | Significant decline | $123,031 |
| Biostatistician * | $109,100 | $140,725 | $175,000 | Moderate increase | $133,322 |
| Validation Engineer * | $95,728 | $105,849 | $119,600 | Significant increase | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Chemung County unemployment ticked up to 4.2% in August 2026 from 4.1% in June, consistent with a civilian labor force that has contracted to roughly 35,700 against a manufacturing base that has shrunk by half since the 1990s and offers little cushion against national hiring softness. New York's pharma and biotech sector hit a record 23,643 statewide jobs even as BioSpace postings fell 39% year-over-year, signaling that life sciences growth is concentrating in downstate and Boston-proximate clusters rather than spreading into upstate labor markets like Elmira.
What it means
Elmira's thin, slow-growing labor force leaves little depth for specialized scientific, regulatory, or CMC roles, pushing build-vs-outsource calculus further toward CDMO and CRO partnerships for execution-critical work that the local market cannot staff competitively. With Clinical Research Associate advertised pay up significantly both locally ($97,647) and nationally ($90,956), local employers chasing clinical talent are bidding against a national market tightening around the same roles, not just regional peers. Organizations should evaluate whether site-based clinical and quality headcount can be right-sized toward remote or CRO-supported models rather than competing directly for scarce upstate talent against downstate and Boston compensation levels.
Looking ahead
Worth watching: Chemung County's unemployment uptick to 4.2% warrants tracking against the next two monthly releases to determine whether labor supply is stabilizing or continuing to contract, directly affecting how aggressively to recruit locally versus remotely.
Emerging pressure point: National biopharma layoffs (BioMarin, Bristol Myers) are concentrated in consolidation functions while 64% of firms keep recruiting — watch whether any displaced regulatory or CMC talent surfaces in the regional candidate pool over the next 60 days.
Potential inflection point: CRA advertised pay rising sharply both locally and nationally suggests the role may be approaching a new compensation floor; a plateau or reversal in the next reading would be the clearer signal to recalibrate offers.
Expected: BLS county-level data for September releases with the usual 4-6 week lag; expect confirmation of whether the labor force contraction seen through August persists into fall hiring cycles.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.